Skip to main content

Advertisement

SpringerLink
Log in

Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz

Teil I: Pathophysiologie und Diagnostik

  • Empfehlungen
  • Published:
Clinical Research in Cardiology Supplements Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7

8 Literatur

  1. Anonymous (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355: 253–259

    Article  PubMed  Google Scholar 

  2. Anonymous (2001) IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 37: S182–S238

    PubMed  Google Scholar 

  3. Anonymous (2002) European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. Nephrol Dial Transplant 17 [Suppl 4]: 1–67

  4. Anonymous (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1–266

    Article  PubMed  Google Scholar 

  5. Anonymous (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143–3421

    PubMed  Google Scholar 

  6. Anonymous (2003) Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42: 1–201

    Google Scholar 

  7. Anonymous (2005) USRDS 2004 annual data report. Am J Kidney Dis 45: 8–280

    Google Scholar 

  8. Abbott KC, Reynolds JC, Taylor AJ et al. (2003) Hospitalized atrial fibrillation after renal transplantation in the United States. Am J Transplant 3: 471–476

    Article  PubMed  Google Scholar 

  9. Agrawal A, Sautter MC, Jones NP (2003) Effects of rosiglitazone maleate when added to a sulfonylurea regimen in patients with type 2 diabetes mellitus and mild to moderate renal impairment: a post hoc analysis. Clin Ther 25: 2754–2764

    Article  PubMed  Google Scholar 

  10. Al Suwaidi J, Reddan DN, Williams K et al. (2002) Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106: 974–980

    Article  PubMed  Google Scholar 

  11. Alonso A, Lau J, Jaber BL et al. (2004) Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 43: 1–9

    Article  PubMed  Google Scholar 

  12. Anavekar NS, McMurray JJ, Velazquez EJ et al. (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285–1295

    Article  PubMed  Google Scholar 

  13. Anderson RJ, O’brien M, MaWhinney S et al. (1999) Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5. Kidney Int 55: 1057–1062

    Article  PubMed  Google Scholar 

  14. Ando M, Iwata A, Ozeki Y et al. (2002) Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. Kidney Int 62: 1757–1763

    Article  PubMed  Google Scholar 

  15. Aspelin P, Aubry P, Fransson SG et al. (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348: 491–499

    Article  PubMed  Google Scholar 

  16. Attallah N, Yassine L, Fisher K et al. (2005) Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention. Clin Nephrol 64: 412–418

    PubMed  Google Scholar 

  17. Aviles RJ, Askari AT, Lindahl B et al. (2002) Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 346: 2047–2052

    Article  PubMed  Google Scholar 

  18. Azar RR, Prpic R, Ho KK et al. (2000) Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 86: 485–489

    Article  PubMed  Google Scholar 

  19. Bardy GH, Lee KL, Mark DB et al. (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352: 225–237

    Article  PubMed  Google Scholar 

  20. Barnett AH, Bain SC, Bouter P et al. (2004) Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 351: 1952–1961

    Article  PubMed  Google Scholar 

  21. Beattie JN, Soman SS, Sandberg KR et al. (2001) Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37: 1191–1200

    PubMed  Google Scholar 

  22. Berger AK, Duval S, Krumholz HM (2003) Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 42: 201–208

    Article  PubMed  Google Scholar 

  23. Bergstrom J, Lindholm B, Lacson E Jr et al. (2000) What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial 13: 163–175

    Article  PubMed  Google Scholar 

  24. Best PJ, Lennon R, Ting HH et al. (2002) The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39: 1113–1119

    Article  PubMed  Google Scholar 

  25. Bianchi S, Bigazzi R, Caiazza A et al. (2003) A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am J Kidney Dis 41: 565–570

    Article  PubMed  Google Scholar 

  26. Biesenbach G, Raml A, Schmekal B et al. (2003) Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients. Diabet Med 20: 642–645

    Article  PubMed  Google Scholar 

  27. Birck R, Krzossok S, Markowetz F et al. (2003) Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362: 598–603

    Article  PubMed  Google Scholar 

  28. Blacher J, Guerin AP, Pannier B et al. (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99: 2434–2439

    PubMed  Google Scholar 

  29. Boccardo P, Remuzzi G, Galbusera M (2004) Platelet dysfunction in renal failure. Semin Thromb Hemost 30: 579–589

    Article  PubMed  Google Scholar 

  30. Bonomini M, Dottori S, Amoroso L et al. (2004) Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia. J Thromb Haemost 2: 1275–1281

    Article  PubMed  Google Scholar 

  31. Bostom AG, Shemin D, Lapane KL et al. (1996) Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study. Atherosclerosis 125: 91–101

    Article  PubMed  Google Scholar 

  32. Braun WE, Marwick TH (1994) Coronary artery disease in renal transplant recipients. Cleve Clin J Med 61: 370–385

    PubMed  Google Scholar 

  33. Braun WE, Phillips DF, Vidt DG et al. (1984) Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 16: 603–607

    PubMed  Google Scholar 

  34. Brenner BM, Cooper ME, de Zeeuw D et al. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861–869

    Article  PubMed  Google Scholar 

  35. Brynne L, McNay JL, Schaefer HG et al. (2001) Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failure. Br J Clin Pharmacol 51: 35–43

    Article  PubMed  Google Scholar 

  36. Budde K, Neumayer HH, Fritsche L et al. (2003) The pharmacokinetics of pioglitazone in patients with impaired renal function. Br J Clin Pharmacol 55: 368–374

    Article  PubMed  Google Scholar 

  37. Burke SK, Dillon MA, Hemken DE et al. (2003) Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients. Adv Ren Replace Ther 10: 133–145

    Article  PubMed  Google Scholar 

  38. Busch M, Franke S, Muller A et al. (2004) Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney Int 66: 338–347

    Article  PubMed  Google Scholar 

  39. Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases – the role of oxidant stress. Circ Res 87: 840–844

    PubMed  Google Scholar 

  40. Califf RM, Phillips HR III, Hindman MC et al. (1985) Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 5: 1055–1063

    PubMed  Google Scholar 

  41. Cannon CP, Braunwald E, McCabe CH et al. (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350: 1495–1504

    Article  PubMed  Google Scholar 

  42. Carrier M, Perrault LP, Jeanmart H et al. (2003) Randomized trial comparing off-pump to on-pump coronary artery bypass grafting in high-risk patients. Heart Surg Forum 6: E89–E92

    PubMed  Google Scholar 

  43. Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62: 245–252

    Article  PubMed  Google Scholar 

  44. Cheung AK, Sarnak MJ, Yan G et al. (2000) Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58: 353–362

    Article  PubMed  Google Scholar 

  45. Chobanian AV, Bakris GL, Black HR et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560–2572

    PubMed  Google Scholar 

  46. Coley CM, Eagle KA (1996) Preoperative assessment and perioperative management of cardiac ischemic risk in noncardiac surgery. Curr Probl Cardiol 21: 289–382

    PubMed  Google Scholar 

  47. Collins AJ, Roberts TL, St Peter WL et al. (2002) United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelines. Am J Kidney Dis 39: 784–795

    PubMed  Google Scholar 

  48. Conlon PJ, Krucoff MW, Minda S et al. (1998) Incidence and long-term significance of transient ST segment deviation in hemodialysis patients. Clin Nephrol 49: 236–239

    PubMed  Google Scholar 

  49. Conti CR (2002) Coronary angiography is still alive and well. Clin Cardiol 25: 253–254

    PubMed  Google Scholar 

  50. Cosin J, Diez J (2002) Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail 4: 507–513

    Article  PubMed  Google Scholar 

  51. Coughlin SR, Mawdsley L, Mugarza JA et al. (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25: 735–741

    Article  PubMed  Google Scholar 

  52. Covic A, Diaconita M, Gusbeth-Tatomir P et al. (2002) Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease. Nephrol Dial Transplant 17: 2170–2177

    Article  PubMed  Google Scholar 

  53. Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2005) Arterial stiffness in renal patients: an update. Am J Kidney Dis 45: 965–977

    Article  PubMed  Google Scholar 

  54. Covic A, Haydar AA, Bhamra-Ariza P et al. (2005) Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol 18: 388–396

    PubMed  Google Scholar 

  55. Dahan M, Viron BM, Faraggi M et al. (1998) Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int 54: 255–262

    Article  PubMed  Google Scholar 

  56. Das MK, Pellikka PA, Mahoney DW et al. (2000) Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol 35: 1647–1653

    Article  PubMed  Google Scholar 

  57. Davies MJ (2000) The pathophysiology of acute coronary syndromes. Heart 83: 361–366

    Article  PubMed  Google Scholar 

  58. de Backer G, Ambrosioni E, Borch-Johnsen K et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 24: 1601–1610

    PubMed  Google Scholar 

  59. de Lemos JA, Hillis LD (1996) Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis. J Am Soc Nephrol 7: 2044–2054

    PubMed  Google Scholar 

  60. De Lima JJ, Sabbaga E, Vieira ML et al. (2003) Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 42: 263–268

    Article  PubMed  Google Scholar 

  61. Devineni D, Walter YH, Smith HT et al. (2003) Pharmacokinetics of nateglinide in renally impaired diabetic patients. J Clin Pharmacol 43: 163–170

    Article  PubMed  Google Scholar 

  62. Dierkes J, Domrose U, Westphal S et al. (2000) Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 102: 1964–1969

    PubMed  Google Scholar 

  63. Dietz R, Rauch B (2003) Guidelines for diagnosis and treatment of chronic coronary heart disease. Issued by the executive committee of the German Society of Cardiology – Heart Circulation Research in cooperation with the German Society for Prevention and Rehabilitation of Cardiac Diseases and the German Society for Thoracic and Cardiovascular Surgery. Z Kardiol 92: 501–521

    PubMed  Google Scholar 

  64. Distante A, Moscarelli E, Morales MA (1991) Pharmacologic methods instead of exercise for the assessment of coronary artery disease. Echocardiography 8: 99–114

    Google Scholar 

  65. Dobashi K, Ghosh B, Orak JK et al. (2000) Kidney ischemia-reperfusion: modulation of antioxidant defenses. Mol Cell Biochem 205: 1–11

    Article  PubMed  Google Scholar 

  66. Dominiak P, Raasch W (1996) ACE-Hemmer in Klinik und Praxis. Springer, Berlin Heidelberg Heidelberg New York Tokyo

  67. Drueke T, Witko-Sarsat V, Massy Z et al. (2002) Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106: 2212–2217

    Article  PubMed  Google Scholar 

  68. Erem C, Kulan K, Tuncer C et al. (1997) Cardiac arrhythmias in patients on maintenance hemodialysis. Acta Cardiol 52: 25–36

    PubMed  Google Scholar 

  69. Erley CM, Bader BD, Berger ED et al. (2004) Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrol Dial Transplant 19: 2526–2531

    Article  PubMed  Google Scholar 

  70. Foley RN, Culleton BF, Parfrey PS et al. (1997) Cardiac disease in diabetic end-stage renal disease. Diabetologia 40: 1307–1312

    Article  PubMed  Google Scholar 

  71. Foley RN, Herzog CA, Collins AJ (2003) Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study. Kidney Int 63: 1462–1467

    Article  PubMed  Google Scholar 

  72. Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9: S16–S23

    Article  PubMed  Google Scholar 

  73. Fox CS, Longenecker JC, Powe NR et al. (2004) Undertreatment of hyperlipidemia in a cohort of United States kidney dialysis patients. Clin Nephrol 61: 299–307

    PubMed  Google Scholar 

  74. Fox KM (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362: 782–788

    Article  PubMed  Google Scholar 

  75. Franga DL, Kratz JM, Crumbley AJ et al. (2000) Early and long-term results of coronary artery bypass grafting in dialysis patients. Ann Thorac Surg 70: 813–818

    Article  PubMed  Google Scholar 

  76. Freeman RV, Mehta RH, Al Badr W et al. (2003) Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol 41: 718–724

    Article  PubMed  Google Scholar 

  77. Frei U, Schober-Halstenberg HJ (1999) Annual Report of the German Renal Registry 1998. QuaSi-Niere Task Group for Quality Assurance in Renal Replacement Therapy. Nephrol Dial Transplant 14: 1085–1090

    Article  PubMed  Google Scholar 

  78. Frenken M, Krian A (1999) Cardiovascular operations in patients with dialysis-dependent renal failure. Ann Thorac Surg 68: 887–893

    Article  PubMed  Google Scholar 

  79. Fritsche L, Budde K, Glander P et al. (2003) Treating type 2 diabetes in renal insufficiency: the role of pioglitazone. Int J Clin Pharmacol Ther 41: 488–491

    PubMed  Google Scholar 

  80. Galle J, Quaschning T (2001) Angiotensin II and atherosclerosis – relevance for renal disease. Contrib Nephrol 19: 235–249

    Google Scholar 

  81. Galle J, Wanner C (1999) Modification of lipoproteins in uremia: oxidation, glycation, and carbamylation. Miner Electrolyte Metab 25: 263–268

    Article  PubMed  Google Scholar 

  82. Germain CDAOS (1987) Electrocardiographic monitoring in children with end-stage renal disease. Dialysis Transplantation 16: 250–251

    Google Scholar 

  83. Go AS, Chertow GM, Fan D et al. (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296–1305

    Article  PubMed  Google Scholar 

  84. Go RT, Marwick TH, MacIntyre WJ et al. (1990) A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 31: 1899–1905

    PubMed  Google Scholar 

  85. Goldsmith DJ, Covic A (2001) Coronary artery disease in patients with renal failure. Int J Clin Pract 55: 196–210

    PubMed  Google Scholar 

  86. Goldwasser P, Mittman N, Antignani A et al. (1993) Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 3: 1613–1622

    PubMed  Google Scholar 

  87. Goodman WG, Goldin J, Kuizon BD et al. (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478–1483

    Article  PubMed  Google Scholar 

  88. Griendling KK, Minieri CA, Ollerenshaw JD et al. (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141–1148

    PubMed  Google Scholar 

  89. Gruberg L, Dangas G, Mehran R et al. (2002) Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 55: 66–72

    Article  PubMed  Google Scholar 

  90. Grundy SM, Cleeman JI, Daniels SR et al. (2006) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21: 1–6

    Article  PubMed  Google Scholar 

  91. Grundy SM, Cleeman JI, Merz CN et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110: 227–239

    PubMed  Google Scholar 

  92. Grundy SM, Howard B, Smith S Jr et al. (2002) Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 105: 2231–2239

    Article  PubMed  Google Scholar 

  93. Grundy SM, Howard B, Smith S Jr et al. (2002) Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 105: 2231–2239

    Article  PubMed  Google Scholar 

  94. Halm EA, Browner WS, Tubau JF et al. (1996) Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of Perioperative Ischemia Research Group. Ann Intern Med 125: 433–441

    PubMed  Google Scholar 

  95. Hannken T, Schroeder R, Zahner G et al. (2000) Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27Kip1: role in angiotensin II- mediated hypertrophy of proximal tubular cells. J Am Soc Nephrol 11: 1387–1397

    PubMed  Google Scholar 

  96. Hansson L, Zanchetti A, Carruthers SG et al. (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351: 1755–1762

    Article  PubMed  Google Scholar 

  97. Harnett JD, Foley RN, Kent GM et al. (1995) Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47: 884–890

    PubMed  Google Scholar 

  98. Harrower AD (1996) Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency. Clin Pharmacokinet 31: 111–119

    PubMed  Google Scholar 

  99. Hasslacher C (2003) Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function. Diabetes Care 26: 886–891

    PubMed  Google Scholar 

  100. Hemmelgarn BR, Southern D, Culleton BF et al. (2004) Survival after coronary revascularization among patients with kidney disease. Circulation 110: 1890–1895

    Article  PubMed  Google Scholar 

  101. Henry RM, Kostense PJ, Bos G et al. (2002) Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int 62: 1402–1407

    Article  PubMed  Google Scholar 

  102. Herzog CA, Ma JZ, Collins AJ (1998) Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339: 799–805

    Article  PubMed  Google Scholar 

  103. Herzog CA, Ma JZ, Collins AJ (2002) Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106: 2207–2211

    Article  PubMed  Google Scholar 

  104. Herzog CA, Marwick TH, Pheley AM et al. (1999) Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 33: 1080–1090

    PubMed  Google Scholar 

  105. Himmelfarb J, Stenvinkel P, Ikizler TA et al. (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62: 1524–1538

    Article  PubMed  Google Scholar 

  106. Hogg RJ, Furth S, Lemley KV et al. (2003) National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111: 1416–1421

    Article  PubMed  Google Scholar 

  107. Holdaas H, Fellstrom B, Jardine AG et al. (2003) Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 361: 2024–2031

    Article  PubMed  Google Scholar 

  108. Holley JL, Fenton RA, Arthur RS (1991) Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med 90: 563–570

    PubMed  Google Scholar 

  109. Hostetter TH (2004) Chronic kidney disease predicts cardiovascular disease. N Engl J Med 351: 1344–1346

    Article  PubMed  Google Scholar 

  110. Hou FF, Zhang X, Zhang GH et al. (2006) Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 354: 131–140

    Article  PubMed  Google Scholar 

  111. Howlett HC, Bailey CJ (1999) A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf 20: 489–503

    Article  PubMed  Google Scholar 

  112. Howse M, Sastry S, Bell GM (2002) Changes in the corrected QT interval and corrected QT dispersion during haemodialysis. Postgrad Med J 78: 273–275

    Article  PubMed  Google Scholar 

  113. Hunink MG, Kuntz KM, Fleischmann KE et al. (1999) Noninvasive imaging for the diagnosis of coronary artery disease: focusing the development of new diagnostic technology. Ann Intern Med 131: 673–680

    PubMed  Google Scholar 

  114. Ichikawa I, Kiyama S, Yoshioka T (1994) Renal antioxidant enzymes: their regulation and function. Kidney Int 45: 1–9

    PubMed  Google Scholar 

  115. Iskander S, Iskandrian AE (1998) Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 32: 57–62

    Article  PubMed  Google Scholar 

  116. Jahangiri M, Wright J, Edmondson S et al. (1997) Coronary artery bypass graft surgery in dialysis patients. Heart 78: 343–345

    PubMed  Google Scholar 

  117. Jialal I, Devaraj S, Venugopal SK (2004) C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44: 6–11

    Article  PubMed  Google Scholar 

  118. Johansen KL, Chertow GM, Ng AV et al. (2000) Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int 57: 2564–2570

    Article  PubMed  Google Scholar 

  119. Jonsson A, Rydberg T, Sterner G et al. (1998) Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function. Eur J Clin Pharmacol 53: 429–435

    Article  PubMed  Google Scholar 

  120. Juurlink DN, Mamdani MM, Lee DS et al. (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351: 543–551

    Article  PubMed  Google Scholar 

  121. Kalantar-Zadeh K, Block G, Humphreys MH et al. (2004) A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 15: 442–453

    Article  PubMed  Google Scholar 

  122. Kamal AM, Fattah AA, Pancholy S et al. (1994) Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease. J Nucl Cardiol 1: 254–261

    PubMed  Google Scholar 

  123. Kasiske B, Cosio FG, Beto J et al. (2004) Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 4 [Suppl 7]: 13–53

  124. Kasiske BL, Guijarro C, Massy ZA et al. (1996) Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7: 158–165

    PubMed  Google Scholar 

  125. Kay J, Chow WH, Chan TM et al. (2003) Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 289: 553

    Article  PubMed  Google Scholar 

  126. Ken M (2004) Cardiovascular surgery in patients on chronic dialysis: effect of intraoperative hemodialysis. Interactive Cardiovasc Thoracic Surg 3: 148–152

    Article  Google Scholar 

  127. Kertai MD, Boersma E, Sicari R et al. (2002) Which stress test is superior for perioperative cardiac risk stratification in patients undergoing major vascular surgery? Eur J Vasc Endovasc Surg 24: 222–229

    Article  PubMed  Google Scholar 

  128. Ketteler M, Bongartz P, Westenfeld R et al. (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361: 827–833

    Article  PubMed  Google Scholar 

  129. Ketteler M, Wanner C, Metzger T et al. (2003) Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. Kidney Int Suppl S84–S87

  130. Kielstein JT, Boger RH, Bode-Boger SM et al. (2002) Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 13: 170–176

    PubMed  Google Scholar 

  131. Kitano Y, Kasuga H, Watanabe M et al. (2004) Severe coronary stenosis is an important factor for induction and lengthy persistence of ventricular arrhythmias during and after hemodialysis. Am J Kidney Dis 44: 328–336

    PubMed  Google Scholar 

  132. Klahr S (1997) Oxygen radicals and renal diseases. Miner Electrolyte Metab 23: 140–143

    PubMed  Google Scholar 

  133. Klahr S, Levey AS, Beck GJ et al. (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330: 877–884

    Article  PubMed  Google Scholar 

  134. Klahr S, Levey AS, Beck GJ et al. (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330: 877–884

    Article  PubMed  Google Scholar 

  135. Knutsen R, Knutsen SF, Curb JD et al. (1988) The predictive value of resting electrocardiograms for 12-year incidence of coronary heart disease in the Honolulu Heart Program. J Clin Epidemiol 41: 293–302

    Article  PubMed  Google Scholar 

  136. Koch M, Gradaus F, Schoebel FC et al. (1997) Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transplant 12: 1187–1191

    Article  PubMed  Google Scholar 

  137. Koch M, Kutkuhn B, Grabensee B et al. (1997) Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. Nephrol Dial Transplant 12: 2603–2611

    Article  PubMed  Google Scholar 

  138. Kramer W, Wizemann V, Thormann J et al. (1986) Cardiac dysfunction in patients on maintenance hemodialysis. I. The importance of associated heart diseases in determining alterations of cardiac performance. Contrib Nephrol 52: 97–109

    PubMed  Google Scholar 

  139. Launay-Vacher V, Izzedine H, Deray G (2005) Statins‘ dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients. Int J Cardiol 101: 9–17

    Article  PubMed  Google Scholar 

  140. Le Feuvre C, Dambrin G, Helft G et al. (2001) Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting. Heart 85: 556–560

    Article  PubMed  Google Scholar 

  141. Le A, Wilson R, Douek K et al. (1994) Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 24: 65–71

    PubMed  Google Scholar 

  142. Lemos PA, Arampatzis CA, Hoye A et al. (2005) Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 95: 167–172

    Article  PubMed  Google Scholar 

  143. Levey AS, Beto JA, Coronado BE et al. (1998) Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32: 853–906

    PubMed  Google Scholar 

  144. Levey AS, Bosch JP, Lewis JB et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461–470

    PubMed  Google Scholar 

  145. Levey AS, Coresh J, Balk E et al. (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139: 137–147

    PubMed  Google Scholar 

  146. Levey AS, Coresh J, Balk E et al. (2003) National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Ann Intern Med 139: 137–147

    PubMed  Google Scholar 

  147. Levin A, Singer J, Thompson CR et al. (1996) Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 27: 347–354

    PubMed  Google Scholar 

  148. Lewis EJ, Hunsicker LG, Clarke WR et al. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851–860

    Article  PubMed  Google Scholar 

  149. Lewis MS, Wilson RA, Walker KW et al. (2002) Validation of an algorithm for predicting cardiac events in renal transplant candidates. Am J Cardiol 89: 847–850

    Article  PubMed  Google Scholar 

  150. Liu JY, Birkmeyer NJ, Sanders JH et al. (2000) Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 102: 2973–2977

    PubMed  Google Scholar 

  151. Liu Y, Coresh J, Eustace JA et al. (2004) Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 291: 451–459

    Article  PubMed  Google Scholar 

  152. Locatelli F, Carbarns IR, Maschio G et al. (1997) Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. Kidney Int Suppl 63: S63–S66

    PubMed  Google Scholar 

  153. Logar CM, Herzog CA, Beddhu S (2003) Diagnosis and therapy of coronary artery disease in renal failure, end-stage renal disease, and renal transplant populations. Am J Med Sci 325: 214–227

    Article  PubMed  Google Scholar 

  154. Lonnemann G (2000) Chronic inflammation in hemodialysis: the role of contaminated dialysate. Blood Purif 18: 214–223

    Article  PubMed  Google Scholar 

  155. MacMahon S, Peto R, Cutler J et al. (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765–774

    Article  PubMed  Google Scholar 

  156. Mailloux LU, Haley WE (1998) Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions. Am J Kidney Dis 32: 705–719

    PubMed  Google Scholar 

  157. Malatino LS, Benedetto FA, Mallamaci F et al. (1999) Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. J Nephrol 12: 256–260

    PubMed  Google Scholar 

  158. Manian FA (2003) Vascular and cardiac infections in end-stage renal disease. Am J Med Sci 325: 243–250

    Article  PubMed  Google Scholar 

  159. Manninen V, Tenkanen L, Koskinen P et al. (1992) Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 85: 37–45

    PubMed  Google Scholar 

  160. Manske CL, Thomas W, Wang Y et al. (1993) Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 44: 617–621

    PubMed  Google Scholar 

  161. Marenzi G, Marana I, Lauri G et al. (2003) The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 349: 1333–1340

    Article  PubMed  Google Scholar 

  162. Marin JM, Carrizo SJ, Vicente E et al. (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365: 1046–1053

    PubMed  Google Scholar 

  163. Marso SP, Ellis SG, Tuzcu M et al. (1999) The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics. J Am Coll Cardiol 33: 1269–1277

    Article  PubMed  Google Scholar 

  164. Marwick TH, Steinmuller DR, Underwood DA et al. (1990) Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 49: 100–103

    PubMed  Google Scholar 

  165. Massy ZA, Khoa TN, Lacour B et al. (1999) Dyslipidaemia and the progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant 14: 2392–2397

    Article  PubMed  Google Scholar 

  166. Matzkies FK, Reinecke H, Regetmeier A et al. (2001) Long-term outcome after percutaneous transluminal coronary angioplasty in patients with chronic renal failure with and without diabetic nephropathy. Nephron 89: 10–14

    Article  PubMed  Google Scholar 

  167. McCullough PA, Sandberg KR, Borzak S et al. (2002) Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 144: 226–232

    Article  PubMed  Google Scholar 

  168. McCullough PA, Wolyn R, Rocher LL et al. (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103: 368–375

    Article  PubMed  Google Scholar 

  169. Meier-Kriesche HU, Schold JD, Srinivas TR et al. (2004) Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant 4: 1662–1668

    Article  PubMed  Google Scholar 

  170. Menon V, Sarnak MJ (2005) The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high-risk combination. Am J Kidney Dis 45: 223–232

    Article  PubMed  Google Scholar 

  171. Merlino G, Piani A, Dolso P et al. (2006) Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant 21: 184–190

    Article  PubMed  Google Scholar 

  172. Merten GJ, Burgess WP, Gray LV et al. (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291: 2328–2334

    Article  PubMed  Google Scholar 

  173. Metcalfe RS, Dawson S, Milne RJ (2003) Heart Protection Study. Lancet 361: 528–530

    Article  Google Scholar 

  174. Milleron O, Pilliere R, Foucher A et al. (2004) Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 25: 728–734

    Article  PubMed  Google Scholar 

  175. Mistry BM, Bastani B, Solomon H et al. (1998) Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Clin Transplant 12: 130–135

    PubMed  Google Scholar 

  176. Morena M, Cristol JP, Bosc JY et al. (2002) Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 17: 422–427

    Article  PubMed  Google Scholar 

  177. Morrow CE, Schwartz JS, Sutherland DE et al. (1983) Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Surg 146: 331–335

    Article  PubMed  Google Scholar 

  178. Moss AJ, Zareba W, Hall WJ et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346: 877–883

    Article  PubMed  Google Scholar 

  179. Mueller C, Buerkle G, Buettner HJ et al. (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162: 329–336

    Article  PubMed  Google Scholar 

  180. Muntner P, Hamm LL, Kusek JW et al. (2004) The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140: 9–17

    PubMed  Google Scholar 

  181. Nagele H, Bohlmann M, Eck U et al. (2000) Combination therapy with carvedilol and amiodarone in patients with severe heart failure. Eur J Heart Fail 2: 71–79

    Article  PubMed  Google Scholar 

  182. Nakao N, Yoshimura A, Morita H et al. (2003) Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 361: 117–124

    Article  PubMed  Google Scholar 

  183. Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39: 930–936

    Article  PubMed  Google Scholar 

  184. National Kidney Foundation (2003) Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42: 1–201

    Google Scholar 

  185. National Kidney Foundation (2005) Guidelines on the evaluation and management of cardiovascular risk factors. Am J Kidney Dis 45: S1–138

    Google Scholar 

  186. Nolan CR (2005) Strategies for improving long-term survival in patients with ESRD. J Am Soc Nephrol 16 [Suppl 2]: S120–S127

    Google Scholar 

  187. Ojanen S, Koobi T, Korhonen P et al. (1999) QRS amplitude and volume changes during hemodialysis. Am J Nephrol 19: 423–427

    Article  PubMed  Google Scholar 

  188. Orth SR, Stockmann A, Conradt C et al. (1998) Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54: 926–931

    Article  PubMed  Google Scholar 

  189. Owen CH, Cummings RG, Sell TL et al. (1994) Coronary artery bypass grafting in patients with dialysis-dependent renal failure. Ann Thorac Surg 58: 1729–1733

    PubMed  Google Scholar 

  190. Packer M, Poole-Wilson PA, Armstrong PW et al. (1999) Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 100: 2312–2318

    PubMed  Google Scholar 

  191. Parving HH, Lehnert H, Brochner-Mortensen J et al. (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345: 870–878

    Article  PubMed  Google Scholar 

  192. Pereira AA, Sarnak MJ (2003) Anemia as a risk factor for cardiovascular disease. Kidney Int Suppl S32–S39

  193. Philipson JD, Carpenter BJ, Itzkoff J et al. (1986) Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 81: 630–634

    Article  PubMed  Google Scholar 

  194. Pitt B, Remme W, Zannad F et al. (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348: 1309–1321

    Article  PubMed  Google Scholar 

  195. Pitt B, Zannad F, Remme WJ et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709–717

    Article  PubMed  Google Scholar 

  196. Pohl MA, Blumenthal S, Cordonnier DJ et al. (2005) Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol 16: 3027–3037

    Article  PubMed  Google Scholar 

  197. Port FK, Hulbert-Shearon TE, Wolfe RA et al. (1999) Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 33: 507–517

    PubMed  Google Scholar 

  198. Powell KL, Smith JM, Woods SE et al. (2004) Coronary artery bypass grafting in patients with dialysis-dependent end stage renal disease: a prospective, nested case-control study. J Card Surg 19: 449–452

    Article  PubMed  Google Scholar 

  199. Raggi P, Boulay A, Chasan-Taber S et al. (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39: 695–701

    Article  PubMed  Google Scholar 

  200. Rahman M, Pressel S, Davis BR et al. (2005) Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 165: 936–946

    Article  PubMed  Google Scholar 

  201. Raine AE, Margreiter R, Brunner FP et al. (1992) Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 7 [Suppl 2]: 7–35

  202. Reinecke H, Matzkies F, Fobker M et al. (2005) Diabetic nephropathy, percutaneous coronary interventions, and blockade of the Renin-Angiotensin system. Cardiology 104: 24–30

    Article  PubMed  Google Scholar 

  203. Reinecke H, Trey T, Matzkies F et al. (2003) Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 63: 696–701

    Article  PubMed  Google Scholar 

  204. Reinecke H, Trey T, Wellmann J et al. (2003) Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 24: 2142–2150

    Article  PubMed  Google Scholar 

  205. Reis G, Marcovitz PA, Leichtman AB et al. (1995) Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 75: 707–710

    Article  PubMed  Google Scholar 

  206. Ridker PM, Cushman M, Stampfer MJ et al. (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973–979

    Article  PubMed  Google Scholar 

  207. Rinehart AL, Herzog CA, Collins AJ et al. (1995) A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 25: 281–290

    PubMed  Google Scholar 

  208. Ritz E (2003) Minor renal dysfunction: an emerging independent cardiovascular risk factor. Heart 89: 963–964

    Article  PubMed  Google Scholar 

  209. Roques F, Nashef SA, Michel P et al. (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15: 816–822

    Article  PubMed  Google Scholar 

  210. Ross R (1999) Mechanisms of disease – Atherosclerosis – an inflammatory disease. N Engl J Med 340: 115–126

    Article  PubMed  Google Scholar 

  211. Rostand SG, Kirk KA, Rutsky EA (1984) Dialysis-associated ischemic heart disease: insights from coronary angiography. Kidney Int 25: 653–659

    PubMed  Google Scholar 

  212. Rostand SG, Kirk KA, Rutsky EA (1986) The epidemiology of coronary artery disease in patients on maintenance hemodialysis: implications for management. Contrib Nephrol 52: 34–41

    PubMed  Google Scholar 

  213. Rubanyi GM, Vanhoutte PM (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250: H822–H827

    PubMed  Google Scholar 

  214. Rubenstein MH, Harrell LC, Sheynberg BV et al. (2000) Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 102: 2966–2972

    PubMed  Google Scholar 

  215. Rubenstein MH, Sheynberg BV, Harrell LC et al. (2001) Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol 87: 856–860

    Article  PubMed  Google Scholar 

  216. Ruggenenti P, Perna A, Gherardi G et al. (1998) Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy. Lancet 352: 1252–1256

    Article  PubMed  Google Scholar 

  217. Rump LC, Amann K, Orth S et al. (2000) Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 15: 1735–1738

    Article  PubMed  Google Scholar 

  218. Ryden L, Armstrong PW, Cleland JG et al. (2000) Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. Eur Heart J 21: 1967–1978

    Article  PubMed  Google Scholar 

  219. Sadeghi HM, Stone GW, Grines CL et al. (2003) Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108: 2769–2775

    Article  PubMed  Google Scholar 

  220. Sawada SG, Segar DS, Ryan T et al. (1991) Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 83: 1605–1614

    PubMed  Google Scholar 

  221. Schein OD, Katz J, Bass EB et al. (2000) The value of routine preoperative medical testing before cataract surgery. Study of Medical Testing for Cataract Surgery. N Engl J Med 342: 168–175

    Article  PubMed  Google Scholar 

  222. Schlant RC, Blomqvist CG, Brandenburg RO et al. (1986) Guidelines for exercise testing. A report of the Joint American College of Cardiology/American Heart Association Task Force on Assessment of Cardiovascular Procedures (Subcommittee on Exercise Testing). Circulation 74: 653A–667A

    PubMed  Google Scholar 

  223. Schmidt A, Stefenelli T, Schuster E et al. (2001) Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 37: 56–63

    PubMed  Google Scholar 

  224. Schoebel FC, Gradaus F, Ivens K et al. (1997) Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography. Heart 78: 337–342

    PubMed  Google Scholar 

  225. Schumacher S, Abbasi I, Weise D et al. (2001) Single- and multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment. Eur J Clin Pharmacol 57: 147–152

    Article  PubMed  Google Scholar 

  226. Schwarz U, Buzello M, Ritz E et al. (2000) Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 15: 218–223

    Article  PubMed  Google Scholar 

  227. Seliger SL, Weiss NS, Gillen DL et al. (2002) HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 61: 297–304

    Article  PubMed  Google Scholar 

  228. Shackelford RE, Kaufmann WK, Paules RS (2000) Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 28: 1387–1404

    Article  PubMed  Google Scholar 

  229. Shlipak MG, Heidenreich PA, Noguchi H et al. (2002) Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137: 555–562

    PubMed  Google Scholar 

  230. Shroyer AL, Coombs LP, Peterson ED et al. (2003) The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 75: 1856–1864

    Article  PubMed  Google Scholar 

  231. Solomon R, Werner C, Mann D et al. (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331: 1416–1420

    Article  PubMed  Google Scholar 

  232. Soman SS, Sandberg KR, Borzak S et al. (2002) The independent association of renal dysfunction and arrhythmias in critically ill patients. Chest 122: 669–677

    Article  PubMed  Google Scholar 

  233. Stack AG, Molony DA, Rives T et al. (2005) Association of physical activity with mortality in the US dialysis population. Am J Kidney Dis 45: 690–701

    Article  PubMed  Google Scholar 

  234. Staessen JA, Wang JG, Thijs L (2003) Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 21: 1055–1076

    Article  PubMed  Google Scholar 

  235. Stary HC, Chandler AB, Dinsmore RE et al. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92: 1355–1374

    PubMed  Google Scholar 

  236. Stenvinkel P (2001) Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 19: 143–151

    Article  PubMed  Google Scholar 

  237. Stenvinkel P, Heimburger O, Paultre F et al. (1999) Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55: 1899–1911

    Article  PubMed  Google Scholar 

  238. Stewart G, Jardine AG, Briggs JD (2000) Ischaemic heart disease following renal transplantation. Nephrol Dial Transplant 15: 269–277

    Article  PubMed  Google Scholar 

  239. Szabo Z, Kakuk G, Fulop T et al. (2002) Effects of haemodialysis on maximum P wave duration and P wave dispersion. Nephrol Dial Transplant 17: 1634–1638

    Article  PubMed  Google Scholar 

  240. Tamura K, Tsuji H, Nishiue T et al. (1998) Determinants of ventricular arrhythmias in hemodialysis patients. Evaluation of the effect of arrhythmogenic substrate and autonomic imbalance. Am J Nephrol 18: 280–284

    Article  PubMed  Google Scholar 

  241. Tepel M, Van der Giet M, Schwarzfeld C et al. (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180–184

    Article  PubMed  Google Scholar 

  242. The expert group on renal transplantation (2000) Evaluation, selection and preparation of the potential transplant recepient. Nephrol Dial Transplant 15: 1–38

    Google Scholar 

  243. Tschope W, Koch M, Thomas B et al. (1993) Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia. Nephron 64: 354–358

    PubMed  Google Scholar 

  244. Tuomilehto J, Borch-Johnsen K, Molarius A et al. (1998) Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 41: 784–790

    Article  PubMed  Google Scholar 

  245. Vaina S, Stefanadis C (2005) Detection of the vulnerable coronary atheromatous plaque. Where are we now? Int J Cardiovasc Intervent 7: 75–87

    Article  PubMed  Google Scholar 

  246. Vaitkus PT (2000) Current status of prevention, diagnosis, and management of coronary artery disease in patients with kidney failure. Am Heart J 139: 1000–1008

    Article  PubMed  Google Scholar 

  247. Vallance P, Leone A, Calver A et al. (1992) Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 20 [Suppl 12]: S60–S62

  248. Vaziri ND, Wang J, Cesario T et al. (1994) Induction, transcription, synthesis, and adsorption of interleukin-1 by dialyzer membranes. J Am Soc Nephrol 4: 1884–1889

    PubMed  Google Scholar 

  249. Vazquez E, Sanchez-Perales C, Borrego F et al. (2000) Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 140: 886–890

    Article  PubMed  Google Scholar 

  250. Vazquez E, Sanchez-Perales C, Garcia-Cortes MJ et al. (2003) Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Int J Cardiol 87: 135–139

    Article  PubMed  Google Scholar 

  251. Vazquez E, Sanchez-Perales C, Lozano C et al. (2003) Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 92: 868–871

    Article  PubMed  Google Scholar 

  252. Viberti G, Wheeldon NM (2002) Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect. Circulation 106: 672–678

    Article  PubMed  Google Scholar 

  253. Vogt B, Ferrari P, Schonholzer C et al. (2001) Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111: 692–698

    Article  PubMed  Google Scholar 

  254. Wang MC, Tsai WC, Chen JY et al. (2005) Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 45: 494–501

    Article  PubMed  Google Scholar 

  255. Wanner C, Krane V, Marz W et al. (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238–248

    Article  PubMed  Google Scholar 

  256. Weber KT (1999) Aldosterone and spironolactone in heart failure. N Engl J Med 341: 753–755

    Article  PubMed  Google Scholar 

  257. Weiner DE, Tighiouart H, Amin MG et al. (2004) Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307–1315

    Article  PubMed  Google Scholar 

  258. Weinrauch LA, D’Elia JA, Healy RW et al. (1978) Asymptomatic coronary artery disease: angiography in diabetic patients before renal transplantation. Relation of findings to postoperative survival. Ann Intern Med 88: 346–348

    PubMed  Google Scholar 

  259. Witko Sarsat V, Friedlander M, Capeillere Blandin C et al. (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49: 1304–1313

    PubMed  Google Scholar 

  260. Wright RS, Reeder GS, Herzog CA et al. (2002) Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137: 563–570

    PubMed  Google Scholar 

  261. Wu MS, Yu CC, Wu CH et al. (1999) Pre-dialysis glycemic control is an independent predictor of mortality in type II diabetic patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 19 [Suppl 2]: S179–S183

  262. Wu MS, Yu CC, Yang CW et al. (1997) Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 12: 2105–2110

    Article  PubMed  Google Scholar 

  263. Yusuf S, Sleight P, Pogue J et al. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145–153

    Article  PubMed  Google Scholar 

  264. Zimmermann J, Herrlinger S, Pruy A et al. (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55: 648–658

    Article  PubMed  Google Scholar 

  265. Zoccali C, Benedetto FA, Maas R et al. (2002) Asymmetric dimethylarginine, C-reactive protein, and carotid intima- media thickness in end-stage renal disease. J Am Soc Nephrol 13: 490–496

    Article  PubMed  Google Scholar 

  266. Reinecke H, Brandenburg V, Dominiak P et al. (2006) Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Teil II. Clin Res Cardiol Suppl (in press)

Download references

Interessenkonflikt

Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik C (Kardiologie/ Angiologie), Universitätsklinikum Münster, 48129 , Münster, Deutschland

    G. Breithardt

Authors
  1. G. Breithardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Holger Reinecke (Schriftführer), Vincent Brandenburg, Peter Dominiak, Jürgen Flöge, Jan Galle, Helmut Geiger, Bernd Grabensee, Fokko de Haan, Klaus Heun, Katrin Ivens, Werner Kleophas, Arno Krian, Johannes Kroll, Bernd Kutkuhn, Johannes Mann, Thomas Philipp, Teut Risler, Bodo E. Strauer, Wilfried Thiel, Günter Breithardt (Koordinator der AdHoc-Arbeitsgruppe)

Corresponding author

Correspondence to G. Breithardt.

Additional information

Gemeinsam erarbeitet von der Arbeitsgemeinschaft Herz und Nieren und einer interdisziplinären AdHoc-Arbeitsgruppe

der Deutschen Gesellschaft für Kardiologie (DGK),

der Gesellschaft für Nephrologie (GfN),

der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie (DGTHG),

dem Bundesverband Niedergelassener Kardiologen (BNK) und

des Verbands Deutsche Nierenzentren der Deutschen Diaylsegesellschaft niedergelassener Ärzte (DDnÄ) e.V.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holger Reinecke (Schriftführer), Vincent Brandenburg, Peter Dominiak, Jürgen Flöge, Jan Galle, Helmut Geiger, Bernd Grabensee, Fokko de Haan, Klaus Heun, Katrin Ivens, Werner Kleophas, Arno Krian, Johannes Kroll, Bernd Kutkuhn, Johannes Mann, Thomas Philipp, Teut Risler, Bodo E. Strauer, Wilfried Thiel, Günter Breithardt (Koordinator der AdHoc-Arbeitsgruppe)., Breithardt, G. Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Clin Res Cardiol Suppl 1, 8–30 (2006). https://doi.org/10.1007/s11789-006-0011-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11789-006-0011-3

Stichworte

Search

Navigation